PBM (Psyence Biomedical Ltd.) Price-to-Projected Revenue Ratio

pacificbayminerals.com (PBM) - corporate logo

Psyence Biomedical Ltd. (PBM) focuses on obtaining permits and land reclamation during metal exploration, which is supported by the forward P/S metric. The indicator reflects the status of the current valuation. The issuer utilizes satellite monitoring and 3D modeling for zinc and copper exploration, while simultaneously developing psilocybin therapy to support cancer patients within its medical ecosystem.

PBM (pacificbayminerals.com) Market Cap to Future Revenue Ratio history from 07/04/2022 to 11/13/2026

Psyence Bio - analytical breakdowns and key metrics (PBM)

- market price and analyst price targets:
Price Chart Psyence Biomedical|PBM - Forecast Levels Chart
- business market valuation indicators:
Market Value Psyence Bio|PBM - Company Buyout Price
- book value of equity indicators:
Accounting Value per Share Psyence Biomedical|PBM - Total Stockholders' Equity|Market Capitalization to Book Value Ratio pacificbayminerals.com|PBM - Company Assets
- company liabilities and liquidity data:
Debt to Equity Psyence Biomedical Ltd.|PBM - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Psyence Biomedical Ltd.|PBM - Company Total Debt|Debts to Book Capitalization Psyence Bio|PBM - Long-Term Debt|Company Current Liabilities Psyence Biomedical|Quick Ratio pacificbayminerals.com
- net income and valuation multiples indicators:
PBM - Company Net Income|Projected Future Earnings Psyence Biomedical Ltd.|PBM - Business Payback Period|Future Price to Earnings Psyence Biomedical Limited|PBM - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Psyence Bio|PBM - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Psyence Biomedical|PBM - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth pacificbayminerals.com|PBM - Earnings per share growth this year|Earnings growth forecast for next year Psyence Biomedical Ltd.
- revenue and sales details:
PBM - Company Gross Revenue|Projected Sales Volume Psyence Biomedical|PBM - Market Cap to Revenue|Forward P/S Multiple Psyence Bio
Analysis of all company metrics:Psyence Biomedical PBM
Original product of Psyence Bio

The forward P/S reflects the dynamics of market expectations regarding revenue, allowing for an assessment of the business's current value through the lens of projected growth rates. An analysis of the forward P/S for Psyence Biomedical Ltd. (PBM) reveals the sensitivity of share prices to operational risks, which is critical for Psyence Biomedical Ltd. (PBM) due to its total reliance on external CRO and CMO contractors in the absence of its own production facilities.

Competitor analysis

Price-to-Projected Revenue Ratio Alkermes ALKS|AVDL (Avadel Pharmaceuticals PLC) - Future Price to Revenue|ATAI - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio GH Research Group GHRS|MNMD (Mind Medicine) - Forward Price-to-Revenue Multiple|Market Cap to Future Revenue Ratio compasspathways.com (CMPS)|LBRX (LB Pharmaceuticals) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Bright Minds Bio DRUG|Price-to-Projected Revenue Ratio Vanda Pharmaceuticals Inc (VNDA)|cybin.com - Market Cap to Projected Revenue|Forward P/S Multiple ANRO (Alto Neuroscience, Inc.)|NRXP - Forward Price-to-Revenue Multiple|Cingulate Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio silopharma.com|CPHI (chinapharmaholdings.com) - Forward Price-to-Revenue Multiple|Clearmind Medicine, Inc. - Forward Price to Sales|SPRC (SciSparc Ltd) - Forward P/S Multiple|Price-to-Projected Revenue Ratio SEEL|Forward P/S Multiple VRPX|Market Cap to Expected Sales Ratio Karuna Therapeutics Inc